Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...

Germany’s Merck MRK1.31%increase; up pointing triangle KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne TECH-0.12%decrease; down pointing triangle for $11.3 billion, in ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade ...

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.

Merck offered $73 per share, implying a 24% premium to Wednesday's close Merck expects deal to close by late 2026 or early 2027 Sees about 140 million euros in cost savings by the third year after ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, ...

Germany's Merck KGaA said it struck a deal to buy U.S. life-science tools supplier Bio-Techne for $11.4 billion, in an early move under its new chief executive to bulk up its life-sciences business.

Germany's Merck KGaA said it struck a deal to buy U.S. lab-tools supplier Bio-Techne for $11.4 billion, in its biggest acquisition in recent years. Merck offered $73 a share in cash to buy Minneapolis ...

CBSE Class 11 Biology Syllabus 2026-27 PDF is available for download. Check the latest chapter-wise syllabus, unit-wise marks distribution, practical syllabus, and direct PDF download link for the ...